Breaking News, Promotions & Moves

BioMarin Names New R&D and Business Development Leaders

Welcomes Dr. Greg Friberg as EVP, Chief Research & Development Officer, and Dr. James Sabry as EVP, Chief Business Officer.

Author Image

By: Charlie Sternberg

Associate Editor

BioMarin Pharmaceutical Inc. has made two new leadership appointments:   Greg Friberg, M.D., as Executive Vice President, Chief Research & Development Officer, succeeding Hank Fuchs, M.D. James Sabry, M.D., Ph.D., as Executive Vice President, Chief Business Officer. Dr. Greg Friberg, EVP, Chief Research & Development Officer Friberg, who will join BioMarin effective Sept. 30, is a leader with nearly two decades of industry experience. He comes to BioMarin from Amgen...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters